ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 82 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $845 | +0.6% | 170 | 0.0% | 0.00% | – |
Q1 2023 | $840 | -100.0% | 170 | -99.9% | 0.00% | -100.0% |
Q4 2022 | $1,722,535 | +172153.5% | 273,853 | +636767.4% | 0.01% | – |
Q3 2022 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -99.8% | 43 | -99.9% | 0.00% | -100.0% |
Q1 2022 | $535,000 | +32.1% | 58,693 | +265.8% | 0.00% | 0.0% |
Q4 2020 | $405,000 | -87.2% | 16,044 | -80.9% | 0.00% | -85.7% |
Q3 2020 | $3,171,000 | -37.1% | 84,088 | -28.6% | 0.01% | -41.7% |
Q2 2020 | $5,040,000 | -0.4% | 117,707 | -32.7% | 0.01% | -7.7% |
Q1 2019 | $5,059,000 | +7.3% | 175,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $4,713,000 | – | 175,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |